Langley, Canada Clinical Trials

A listing of Langley, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Galderma Investigational Site 8161
 (9.6 away) Contact site
  • 21 views
  • 04 Aug, 2021
  • +474 other locations
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

Psoriasis (PsO) is a chronic disease characterized by marked inflammation of the skin that results in thick, red, scaly plaques. This study will assess how safe and effective risankizumab is compared to apremilast in adult participants with moderate plaque psoriasis. Adverse events and change in disease symptoms will be monitored. …

risankizumab
apremilast
systemic therapy
arthritis
plaque psoriasis
Dr. Chih-ho Hong Medical Inc. /ID# 230337
 (8.7 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +61 other locations
Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack

The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of a dual antiplatelet therapy (acetylsalicylic acid +/- clopidogrel) in patients following a recent heart attack …

angiography
antiplatelet therapy
clot
clopidogrel
troponin
Surrey Memorial Hospital
 (9.6 away) Contact site
  • 57 views
  • 04 Aug, 2021
  • +192 other locations
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

mirikizumab
plaque psoriasis
Dr. Chih-ho Hong Medical Inc.
 (8.7 away) Contact site
  • 717 views
  • 27 Jul, 2021
  • +354 other locations
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo in the treatment of participants in heart failure with a reduced ejection fraction and with iron deficiency

natriuretic peptide
nt-probnp
ejection fraction
bypass graft
nesiritide
SMH Cardiology Clinical Trials
 (9.6 away) Contact site
  • 5316 views
  • 02 Aug, 2021
  • +365 other locations
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming …

adjuvant chemotherapy
core needle biopsy
aromatase inhibitor
hormone therapy
sentinel lymph node biopsy
BCCA-Fraser Valley Cancer Centre
 (9.6 away) Contact site
  • 598 views
  • 25 Jul, 2021
  • +318 other locations
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

asthma
montelukast
ultraviolet light
topical agents
corticosteroids
Dr. Chih-ho Hong Medical Inc.
 (8.7 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +84 other locations
Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo

Vitiligo is a common chronic autoimmune disease that causes the body's immune system to attack its own pigment producing skin cells. This study is to evaluate how safe and effective upadacitinib is in participants with non-segmental vitiligo. Adverse effects and change in disease activity will be assessed. Upadacitinib is being …

Dr. Chih-ho Hong Medical Inc. /ID# 228403
 (8.7 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +43 other locations
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

This is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study of the efficacy and safety of apremilast (CC-10004) in pediatric subjects with moderate to severe plaque psoriasis. At least 230 pediatric subjects (ages 6 through 17 years) will be randomized 2:1 to receive either apremilast or placebo for the first …

apremilast
systemic therapy
cc-10004
topical agents
plaque psoriasis
Research Site
 (8.7 away) Contact site
  • 98 views
  • 04 Aug, 2021
  • +284 other locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

lebrikizumab
topical agents
atopy
progestogen
eczema
Dr. Chih-ho Hong Medical Inc.
 (8.7 away) Contact site
  • 154 views
  • 31 Jul, 2021
  • +346 other locations